Sonendo, Inc. (SONX)

USD 1.15

(-14.81%)

Operating Expenses Summary of Sonendo, Inc.

  • Sonendo, Inc.'s latest annual operating expenses in 2023 was 68.46 Million USD , down -3.36% from previous year.
  • Sonendo, Inc.'s latest quarterly operating expenses in 2024 Q2 was 9.8 Million USD , down -19.98% from previous quarter.
  • Sonendo, Inc. reported a annual operating expenses of 68.68 Million USD in annual operating expenses 2022, up 30.87% from previous year.
  • Sonendo, Inc. reported a annual operating expenses of 52.48 Million USD in annual operating expenses 2021, up 11.29% from previous year.
  • Sonendo, Inc. reported a quarterly operating expenses of 9.8 Million USD for 2024 Q2, down -19.98% from previous quarter.
  • Sonendo, Inc. reported a quarterly operating expenses of 18.16 Million USD for 2023 Q1, up 0.37% from previous quarter.

Annual Operating Expenses Chart of Sonendo, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Sonendo, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 68.46 Million USD -3.36%
2022 68.68 Million USD 30.87%
2021 52.48 Million USD 11.29%
2020 47.15 Million USD -13.52%
2019 54.52 Million USD 0.0%

Peer Operating Expenses Comparison of Sonendo, Inc.

Name Operating Expenses Operating Expenses Difference
Acutus Medical, Inc. 11.22 Million USD -509.988%
Biotricity, Inc. 17.18 Million USD -298.41%
Cell MedX Corp. 313.43 Thousand USD -21743.793%
Dynatronics Corporation 9.9 Million USD -591.005%
Nemaura Medical Inc. 7.13 Million USD -859.054%
PetVivo Holdings, Inc. 11.36 Million USD -502.639%
RetinalGenix Technologies Inc. 2.08 Million USD -3180.469%
Telesis Bio, Inc. 63.48 Million USD -7.838%
Talis Biomedical Corporation 67.18 Million USD -1.904%
Viveve Medical, Inc. 22.17 Million USD -208.776%